FDA approves new Alzheimer's treatment, donanemab from Eli Lilly
The Food and Drug Administration approved a new Alzheimer's treatment called donanemab on Tuesday, c...
The Food and Drug Administration approved a new Alzheimer's treatment called donanemab on Tuesday, c...
Fighting rising prescription drug costs Fighting rising prescription drug costs 07:59 Pharmaceutical...
The Food and Drug Administration approved a request by Eli Lilly on Wednesday to begin marketing its...
Jack Hanna's family recently spoke about his Alzheimer's diagnosis for the first time publicly. The ...
WASHINGTON — Eli Lilly and Co. said Wednesday its experimental Alzheimer's drug appeared to slow wor...